| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Genitourinary Imaging |
1 From the Departments of Medical Physics (K.L.Z., A.S.D., M.M., J.A.K.), Radiology (K.L.Z., H.H., H.N.C., A.S.D., S.E., L.E., J.A.K.), Pathology (K.S., V.E.R.), Urology (M.W.K., P.T.S.), Epidemiology and Biostatistics (M.W.K.), and Medicine (J.A.K.), Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021. From the 2002 RSNA Annual Meeting. Received February 24, 2004; revision requested April 7; revision received June 2; accepted July 1. Supported by National Institutes of Health grants R21 CA 84258-01 and 7-R01 CA76423. Address correspondence to K.L.Z. (e-mail: zakiank@mskcc.org).
PURPOSE: To determine whether hydrogen 1 magnetic resonance (MR) spectroscopic imaging can be used to predict aggressiveness of prostate cancer.
MATERIALS AND METHODS: All patients gave informed consent according to an institutionally approved research protocol. A total of 123 patients (median age, 58 years; age range, 40–74 years) who underwent endorectal MR imaging and MR spectroscopic imaging between January 2000 and December 2002 were included. MR imaging and spectroscopy were performed by using combined pelvic phased-array and endorectal probe. Water and lipids were suppressed, and phase-encoded data were acquired with 6.2-mm resolution. Voxels in the peripheral zone were considered suspicious for cancer if (Cho + Cr)/Cit was at least two standard deviations above the normal level, where Cho represents choline-containing compounds, Cr represents creatine and phosphocreatine, and Cit represents citrate. Correlation between metabolite ratio and four Gleason score groups identified at step-section pathologic evaluation (3 + 3, 3 + 4, 4 + 3, and 
4 + 4) was assessed with generalized estimating equations.
RESULTS: Data from 94 patients were included. Pathologic evaluation was used to identify 239 lesions. Overall sensitivity of MR spectroscopic imaging was 56% for tumor detection, increasing from 44% in lesions with Gleason score of 3 + 3 to 89% in lesions with Gleason score greater than or equal to 4 + 4. There was a trend toward increasing (Cho + Cr)/Cit with increasing Gleason score in lesions identified correctly with MR spectroscopic imaging. Tumor volume assessed with MR spectroscopic imaging increased with increasing Gleason score.
CONCLUSION: MR spectroscopic imaging measurement of prostate tumor (Cho + Cr)/Cit and tumor volume correlate with pathologic Gleason score. There is overlap between MR spectroscopic imaging parameters at various Gleason score levels, which may reflect methodologic and physiologic variations. MR spectroscopic imaging has potential in noninvasive assessment of prostate cancer aggressiveness.
© RSNA, 2005
This article has been cited by other articles:
|
|
 |
|
  T. Franiel, L. Ludemann, B. Rudolph, H. Rehbein, C. Stephan, M. Taupitz, and D. Beyersdorff Prostate MR Imaging: Tissue Characterization with Pharmacokinetic Volume and Blood Flow Parameters and Correlation with Histologic Parameters Radiology, July 1, 2009; 252(1): 101 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Kelloff, P. Choyke, D. S. Coffey, and for The Prostate Cancer Imaging Working Group Challenges in Clinical Prostate Cancer: Role of Imaging Am. J. Roentgenol., June 1, 2009; 192(6): 1455 - 1470. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shukla-Dave, H. Hricak, N. Ishill, C. S. Moskowitz, M. Drobnjak, V. E. Reuter, K. L. Zakian, P. T. Scardino, and C. Cordon-Cardo Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles Clin. Cancer Res., June 1, 2009; 15(11): 3842 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shukla-Dave, H. Hricak, N. M. Ishill, C. S. Moskowitz, M. Drobnjak, V. E. Reuter, K. L. Zakian, P. T. Scardino, and C. Cordon-Cardo Correlation of MR Imaging and MR Spectroscopic Imaging Findings with Ki-67, Phospho-Akt, and Androgen Receptor Expression in Prostate Cancer Radiology, March 1, 2009; 250(3): 803 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Lim, J. K. Kim, K. A. Kim, and K.-S. Cho Prostate Cancer: Apparent Diffusion Coefficient Map with T2-weighted Images for Detection--A Multireader Study Radiology, January 1, 2009; 250(1): 145 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Albers, R. Bok, A. P. Chen, C. H. Cunningham, M. L. Zierhut, V. Y. Zhang, S. J. Kohler, J. Tropp, R. E. Hurd, Y.-F. Yen, et al. Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading Cancer Res., October 15, 2008; 68(20): 8607 - 8615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Cabrera, F. V. Coakley, A. C. Westphalen, Y. Lu, S. Zhao, K. Shinohara, P. R. Carroll, and J. Kurhanewicz Prostate Cancer: Is Inapparent Tumor at Endorectal MR and MR Spectroscopic Imaging a Favorable Prognostic Finding in Patients Who Select Active Surveillance? Radiology, May 1, 2008; 247(2): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Mazaheri, A. Shukla-Dave, H. Hricak, S. W. Fine, J. Zhang, G. Inurrigarro, C. S. Moskowitz, N. M. Ishill, V. E. Reuter, K. Touijer, et al. Prostate Cancer: Identification with Combined Diffusion-weighted MR Imaging and 3D 1H MR Spectroscopic Imaging--Correlation with Pathologic Findings Radiology, February 1, 2008; 246(2): 480 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Sah, R. Sharma, H. Kandpal, A. Seith, S. Rastogi, S. Bandhu, and N. R. Jagannathan In Vivo Proton Spectroscopy of Giant Cell Tumor of the Bone Am. J. Roentgenol., February 1, 2008; 190(2): W133 - W139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Glunde, T. Shah, P. T. Winnard Jr., V. Raman, T. Takagi, F. Vesuna, D. Artemov, and Z. M. Bhujwalla Hypoxia Regulates Choline Kinase Expression through Hypoxia-Inducible Factor-1{alpha} Signaling in a Human Prostate Cancer Model Cancer Res., January 1, 2008; 68(1): 172 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Westphalen, F. V. Coakley, A. Qayyum, M. Swanson, J. P. Simko, Y. Lu, S. Zhao, P. R. Carroll, B. M. Yeh, and J. Kurhanewicz Peripheral Zone Prostate Cancer: Accuracy of Different Interpretative Approaches with MR and MR Spectroscopic Imaging Radiology, December 1, 2007; 246(1): 177 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, Y. Mazaheri, J. Zhang, N. M. Ishill, K. Kuroiwa, and H. Hricak Assessment of Biologic Aggressiveness of Prostate Cancer: Correlation of MR Signal Intensity with Gleason Grade after Radical Prostatectomy Radiology, December 1, 2007; 246(1): 168 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. J. Scheenen, S. W. T. P. J. Heijmink, S. A. Roell, C. A. Hulsbergen Van de Kaa, B. C. Knipscheer, J. A. Witjes, J. O. Barentsz, and A. Heerschap Three-dimensional Proton MR Spectroscopy of Human Prostate at 3 T without Endorectal Coil: Feasibility Radiology, November 1, 2007; 245(2): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shukla-Dave, H. Hricak, C. Moskowitz, N. Ishill, O. Akin, K. Kuroiwa, J. Spector, M. Kumar, V. E. Reuter, J. A. Koutcher, et al. Detection of Prostate Cancer with MR Spectroscopic Imaging: An Expanded Paradigm Incorporating Polyamines Radiology, November 1, 2007; 245(2): 499 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. T. P. J. Heijmink, J. J. Futterer, T. Hambrock, S. Takahashi, T. W. J. Scheenen, H. J. Huisman, C. A. Hulsbergen-Van de Kaa, B. C. Knipscheer, L. A. L. M. Kiemeney, J. A. Witjes, et al. Prostate Cancer: Body-Array versus Endorectal Coil MR Imaging at 3 T--Comparison of Image Quality, Localization, and Staging Performance Radiology, July 1, 2007; 244(1): 184 - 195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hricak, P. L. Choyke, S. C. Eberhardt, S. A. Leibel, and P. T. Scardino Imaging Prostate Cancer: A Multidisciplinary Perspective Radiology, April 1, 2007; 243(1): 28 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Reinsberg, G. S. Payne, S. F. Riches, S. Ashley, J. M. Brewster, V. A. Morgan, and N. M. deSouza Combined Use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection Am. J. Roentgenol., January 1, 2007; 188(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Choi, J. K. Kim, N. Kim, K. W. Kim, E. K. Choi, and K.-S. Cho Functional MR Imaging of Prostate Cancer RadioGraphics, January 1, 2007; 27(1): 63 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Futterer, S. W. T. P. J. Heijmink, T. W. J. Scheenen, J. Veltman, H. J. Huisman, P. Vos, C. A. H.-V. de Kaa, J. A. Witjes, P. F. M. Krabbe, A. Heerschap, et al. Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging Radiology, November 1, 2006; 241(2): 449 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, H. Hricak, M. W. Kattan, H.-N. Chen, P. T. Scardino, and K. Kuroiwa Prediction of Organ-confined Prostate Cancer: Incremental Value of MR Imaging and MR Spectroscopic Imaging to Staging Nomograms Radiology, December 12, 2005; (2005) 2382041905. [Abstract] [Full Text]
|
|
